Paper1988235
Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.
Rieder MJ and 4 others. Clin Pharmacol Ther, 1991. Cited by 177 papers, by iCite.
Cite this record
ConductScience Library. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Papers, record 1988235. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1988235
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Hypersensitivity | Major topic |
| Hypersensitivity, Delayed | Major topic |
| Phenotype | Major topic |
| Sulfonamides | Major topic |
| Acetylation | |
| Adolescent | |
| Caffeine | |
| Chromatography, High Pressure Liquid | |
| Female | |
| Humans | |
| Male |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41344065 | N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation. | Drug Metab Dispos | 2025 | https://conductscience.org/library/papers/41344065 | PubMed |
| 40473510 | Updates in the pathogenesis of SJS/TEN. | Allergol Int | 2025 | https://conductscience.org/library/papers/40473510 | PubMed |
| 38588579 | Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis. | Toxicol Sci | 2024 | https://conductscience.org/library/papers/38588579 | PubMed |
| 38559511 | Fatal Itching and Failing Liver: A Case Report and Literature Review of Rare, Atypical DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Syndrome. | Cureus | 2024 | https://conductscience.org/library/papers/38559511 | PubMed |
| 36838310 | Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses. | Microorganisms | 2023 | https://conductscience.org/library/papers/36838310 | PubMed |
| 36457619 | Trimethoprim-Sulfamethoxazole-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Complicated by Acute Liver Failure. | Cureus | 2022 | https://conductscience.org/library/papers/36457619 | PubMed |
| 30830064 | Drug reaction with eosinophilia and systemic symptoms (DRESS) in children. | Acta Biomed | 2019 | https://conductscience.org/library/papers/30830064 | PubMed |
| 28762467 | Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. | Clin Pharmacol Ther | 2018 | https://conductscience.org/library/papers/28762467 | PubMed |
| 26903698 | Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study. | Niger Med J | 2015 | https://conductscience.org/library/papers/26903698 | PubMed |
| 25999246 | Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. | Dig Dis Sci | 2015 | https://conductscience.org/library/papers/25999246 | PubMed |
| 22850190 | Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity. | Pharmacogenet Genomics | 2012 | https://conductscience.org/library/papers/22850190 | PubMed |
| 22816446 | Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity. | J Vet Intern Med | 2012 | https://conductscience.org/library/papers/22816446 | PubMed |
| 22345792 | Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum. | Indian J Dermatol | 2011 | https://conductscience.org/library/papers/22345792 | PubMed |
| 21878835 | Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity. | Pharmacogenet Genomics | 2011 | https://conductscience.org/library/papers/21878835 | PubMed |
| 21716938 | Cutaneous drug hypersensitivity: immunological and genetic perspective. | Indian J Dermatol | 2011 | https://conductscience.org/library/papers/21716938 | PubMed |
| 21327704 | Drug-induced autoimmune-like hepatitis. | Dig Dis Sci | 2011 | https://conductscience.org/library/papers/21327704 | PubMed |
| 20528732 | Embryonic and induced pluripotent stem cells as a model for liver disease. | Crit Rev Biomed Eng | 2009 | https://conductscience.org/library/papers/20528732 | PubMed |
| 20394749 | Risk factors for idiosyncratic drug-induced liver injury. | Gastroenterology | 2010 | https://conductscience.org/library/papers/20394749 | PubMed |
| 19689281 | Current concepts of mechanisms in drug-induced hepatotoxicity. | Curr Med Chem | 2009 | https://conductscience.org/library/papers/19689281 | PubMed |
| 16584129 | Genetic factors in the predisposition to drug-induced hypersensitivity reactions. | AAPS J | 2006 | https://conductscience.org/library/papers/16584129 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1988235
GET https://conductscience.org/api/papers/v1/1988235/cited_by?page=2